Delhi

Delhi, Education, Home

#FreshStart Monday

Another month of 2020 is ending and so is the virus. Yes, the number of cases is still quite significant but at the same time, the recovery rate is increasing rapidly. While another Monday rings the doorbell, here are some more positive news to have a good start to the …

Delhi, Exclusive

Recovery rate touches new high, nearly 64% today

NEW DELHI 26 July 2020 – Highest ever recoveries registered in a single day; more than 36,000 patients discharged Recoveries outnumber active COVID cases by more than 4 lakh Yesterday recorded the highest ever recoveries in a single day. 36,145 COVID-19 patients were cured and discharged in the last 24 hours. …

Delhi, Himachal Pradesh, Home

Coronavirus Update

Arunachal Pradesh: July 26, 2020: In Arunachal Pradesh, the rapid response teams found 35 people COVID positive after antigen test in the Itanagar Capital Region. Deputy Commissioner, Itanagar Capital Region issues guidelines for truck drivers entering in the state of Arunachal. Drivers carrying negative test report (not older than five …

Delhi, Exclusive

Coffee Day owed $472 million by deceased founder’s firm

BENGALURU 25 July 2020 – An entity linked to the deceased founder of India’s Coffee Day Enterprises Ltd owed the coffee chain 35.35 billion rupees ($472.5 million), an investigation report released by the company showed on Friday. Coffee Day founder V.G. Siddhartha was found dead in a river in southern …

Delhi, Exclusive

Record numbers of coronavirus cases in every global region

25 July 2020 – Almost 40 countries have reported record single-day increases in coronavirus infections over the past week, around double the number that did so the previous week, showing a pick-up in the pandemic in every region of the world. The rate of cases has been increasing not only …

Delhi, Exclusive

Cipla gets India approval to sell COVID-19 drug favipiravir

BENGALURU 25 July 2020 – Cipla Ltd has received Indian regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drugmaker said on Friday, as coronavirus infections in the world’s third worst-hit nation show no sign of abating. The Drug Controller General of India granted Cipla accelerated approval to …